Privately-held NeoRx Corp said entered exclusive agreement Genentech Inc development injectable diagnostic image blood clot .
It said Genentech responsible marketing , NeoRx receive royalty based sale .
The product use proprietary NeoRx method attaching radioisotope technetium-99m Genentech 's blood clot dissolving drug tissue plasminogen activator , Activase .
Reuter & # 3 ; 